Time to BBVNA Relief
NCT07433634
This study is recruiting at 3 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
Basivertebral nerve ablation (BVNA) is a minimally invasive procedure approved for vertebrogenic low back pain. While early studies support its efficacy, real-world evidence is still evolving, particularly regarding the trajectory of pain relief and functional improvement over time, and predictors of clinical response. This study aims to evaluate clinical outcomes longitudinally following BVNA and identify baseline predictors of response.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Low Back Pain
- Vertebrogenic Pain Syndrome
- Basivertebral Nerve Ablation
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Yale University
- Last updated on ClinicalTrials.gov
- March 3, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Connecticut · 3
- Yale Spine and Pain Center - Guilford · Guilford, CT
- Yale Pain Management Center - New Haven · New Haven, CT
- Yale Interventional Spine and Musculoskeletal Medicine - Old Saybrook · Old Saybrook, CT
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.